We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

19 hedge funds and large institutions have $1.9M invested in HCW Biologics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

46% more capital invested

Capital invested by funds: $1.3M → $1.9M (+$598K)

12% more funds holding

Funds holding: 17 → 19 (+2)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$97.5K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$53.1K
3
Jane Street
Jane Street
New York
+$23K
4
Bank of America
Bank of America
North Carolina
+$639
5
APP
Avantax Planning Partners
Iowa
+$320

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$223K
2
Citadel Advisors
Citadel Advisors
Florida
-$12.7K
3
BlackRock
BlackRock
New York
-$1.28K
4
FWM
Focused Wealth Management
New York
-$1.23K
5
TRCT
Tower Research Capital (TRC)
New York
-$959
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
1
HighTower Advisors
Illinois
$316K – – –
APP
2
Avantax Planning Partners
Iowa
$315K +$320 +1 +0.1%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$291K +$53.1K +166 +30%
CAM
4
Cresset Asset Management
Illinois
$231K – – –
PIM
5
Pullen Investment Management
Florida
$149K +$113K +355 New
BCM
6
Bridgeway Capital Management
Texas
$141K – – –
HF
7
HRT Financial
New York
$122K +$97.5K +305 New
BlackRock
8
BlackRock
New York
$80.6K -$1.28K -4 -2%
Vanguard Group
9
Vanguard Group
Pennsylvania
$65.9K -$223K -698 -82%
AWM
10
AE Wealth Management
Kansas
$52.5K – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$39.6K – – –
State Street
12
State Street
Massachusetts
$35.8K – – –
Jane Street
13
Jane Street
New York
$30.2K +$23K +72 New
Northern Trust
14
Northern Trust
Illinois
$17.9K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$8.64K -$959 -3 -13%
UBS Group
16
UBS Group
Switzerland
$1.06K – – –
Bank of America
17
Bank of America
North Carolina
$710 +$639 +2 New
Wells Fargo
18
Wells Fargo
California
$247 – – –
JP Morgan Chase
19
JP Morgan Chase
New York
$15 – – –
Citadel Advisors
20
Citadel Advisors
Florida
– -$12.7K -43 Closed
FWM
21
Focused Wealth Management
New York
– -$1.23K -4 Closed

HCWB Hedge Fund Activity: Q1 2024 in Review

19 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q1 2024, worth a combined $1.9M — up 46% from $1.3M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HCWB positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $97.5K. The largest seller was Vanguard Group, cutting an estimated $223K.

  • 19 institutional investors held HCW Biologics (HCWB) as of Q1 2024, up from 17 in Q4 2023.
  • Funds reported $1.9M of HCW Biologics stock for Q1 2024, up 46% quarter-over-quarter.
  • 4 funds opened new HCW Biologics positions in Q1 2024 and 2 closed out, a net change of +2 holders.
  • The largest HCW Biologics buyer in Q1 2024 was HRT Financial, an estimated $97.5K added.
  • The largest HCW Biologics seller in Q1 2024 was Vanguard Group, an estimated $223K sold.

Based on aggregated 13F filings for Q1 2024.